We are live on
!
Find out more
GWCM
Godshalk Welsh Capital Management Portfolio holdings
AUM
$172M
1-Year Est. Return
16.03%
This Fund
S&P 500
This Quarter
Est. Return
+9.6%
1 Year Est. Return
+16.03%
3 Year Est. Return
+54.69%
5 Year Est. Return
+73.83%
10 Year Est. Return
+285.54%
AUM
$137M
AUM Growth
+$1.65M
(+1.2%)
Cap. Flow
-$9.64M
Cap. Flow
% of AUM
-7.03%
Top 10 Holdings %
Top 10 Hldgs %
28.94%
Holding
122
New
5
Increased
6
Reduced
88
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$330K |
| 2 |
Mastercard
MA
|
+$313K |
| 3 |
Labcorp
LH
|
+$254K |
| 4 |
Vanguard Consumer Discretionary ETF
VCR
|
+$231K |
| 5 |
WEC Energy
WEC
|
+$199K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Globus Medical
GMED
|
+$1.76M |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$650K |
| 3 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$617K |
| 4 |
Apple
AAPL
|
+$538K |
| 5 |
Microsoft
MSFT
|
+$440K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.5% |
| 2 | Healthcare | 15.98% |
| 3 | Consumer Staples | 11.7% |
| 4 | Financials | 11.36% |
| 5 | Consumer Discretionary | 6.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Quest Diagnostics
DGX
$26.2B
| $567K | 0.41% |
3,625
| – | – |
|
77
Verizon
VZ
$196B
| $556K | 0.41% |
14,105
-4,225
| -23% | -$159K |
|
78
Consolidated Edison
ED
$39.8B
| $515K | 0.38% |
5,400
| – | – |
|
79
DuPont de Nemours
DD
$19.5B
| $508K | 0.37% |
5,903
-297
| -5% | -$23.7K |
|
80
Hershey
HSY
$36.6B
| $486K | 0.35% |
2,100
-240
| -10% | -$55.3K |
|
81
Walt Disney
DIS
$179B
| $459K | 0.34% |
5,287
-770
| -13% | -$73.6K |
|
82
Invesco QQQ Trust
QQQ
$478B
| $445K | 0.32% |
1,672
| – | – |
|
83
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.55B
| $443K | 0.32% |
8,350
-500
| -6% | -$26.2K |
|
84
Bristol-Myers Squibb
BMY
$130B
| $421K | 0.31% |
5,850
-80
| -1% | -$6.03K |
|
85
Danaher
DHR
$146B
| $418K | 0.3% |
1,777
| – | – |
|
86
Clorox
CLX
$13.1B
| $396K | 0.29% |
2,825
| – | – |
|
87
Intel
INTC
$493B
| $392K | 0.29% |
14,824
-2,700
| -15% | -$75K |
|
88
Abbott
ABT
$190B
| $385K | 0.28% |
3,507
-75
| -2% | -$7.77K |
|
89
iShares Core S&P US Growth ETF
IUSG
$33.6B
| $371K | 0.27% |
4,545
-651
| -13% | -$54.4K |
|
90
Corning
GLW
$137B
| $344K | 0.25% |
10,775
-750
| -7% | -$24.3K |
|
91
Masco
MAS
$15B
| $338K | 0.25% |
7,250
| – | – |
|
|
92
Elevance Health
ELV
$84.7B
| $333K | 0.24% |
+650
| New | +$330K |
|
|
93
Mastercard
MA
$492B
| $330K | 0.24% |
+950
| New | +$313K |
|
94
Republic Services
RSG
$65.9B
| $297K | 0.22% |
2,300
-50
| -2% | -$6.67K |
|
95
3M
MMM
$94.4B
| $295K | 0.22% |
2,942
-239
| -8% | -$24.4K |
|
96
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.73B
| $294K | 0.21% |
6,225
-138
| -2% | -$6.49K |
|
97
BHP
BHP
$229B
| $292K | 0.21% |
4,700
-200
| -4% | -$11.2K |
|
98
Union Pacific
UNP
$174B
| $266K | 0.19% |
1,285
-37
| -3% | -$7.59K |
|
|
99
Labcorp
LH
$26.1B
| $263K | 0.19% |
+1,298
| New | +$254K |
|
100
Coca-Cola
KO
$372B
| $261K | 0.19% |
4,100
-436
| -10% | -$26.3K |
|
Similar funds
TA
CRFG
BAM
RPSM
BIA
SPF
KIM
AIM
Godshalk Welsh Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Godshalk Welsh Capital Management held 122 positions worth $137M, up 1.2% from $135M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Godshalk Welsh Capital Management withdrew a net $9.64M in Q4 2022, closing 9 positions and reducing 88 holdings. Its most notable exit was Southern Company, an estimated $274K position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, Godshalk Welsh Capital Management opened a new position in Elevance Health worth $333K.
- Godshalk Welsh Capital Management's largest Q4 2022 buy was Elevance Health: 650 shares worth $333K.
- Godshalk Welsh Capital Management added most to iShares Core Moderate Allocation ETF in Q4 2022, an estimated $144K increase.
- Godshalk Welsh Capital Management's biggest Q4 2022 reduction was Globus Medical, cutting an estimated $1.76M.
- Godshalk Welsh Capital Management fully exited Southern Company in Q4 2022, selling an estimated $274K.
- Godshalk Welsh Capital Management's ten largest holdings make up 29% of its $137M portfolio in Q4 2022.
- Godshalk Welsh Capital Management opened 5 new positions and closed 9 in Q4 2022.
- Godshalk Welsh Capital Management's portfolio value rose 1.2% quarter-over-quarter to $137M.
Based on Godshalk Welsh Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.